RDHL
$0.82
Redhill Biophrma ADR
($.03)
(3.54%)
RDHL
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus:  ($0.30)
Revenue:  N/A
Thursday
Sep 22
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RDHL reports earnings?
Beat
Meet
Miss

Where is RDHL's stock price going from here?
Up
Flat
Down
Stock chart of RDHL
Analysts
Summary of analysts' recommendations for RDHL
Score
Grade
Pivots
Resistance
$0.98
$0.94
$0.90

$0.86

Support
$0.82
$0.78
$0.74
Tweet
Growth
Description
RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.